Influence
September 10, 2021

Regenstrief CEO co-authors AHRQ blog calling for action to achieve health equity

Regenstrief Institute President and Chief Executive Officer Peter Embí, M.D., M.S., joined with other health leaders to call for action to address health disparities in the United States.  

Dr. Embí and fellow members of the Agency for Healthcare Research and Quality (AHRQ)’s National Advisory Council wrote a blog about strategies to make meaningful changes to improve health equity. The authors gave examples of how COVID-19 displayed disparities and exposed the impact of systemic racism.  

To move forward, the authors urge more focus on social determinants of health. They believe AHRQ research could give healthcare providers the tools to understand individuals more holistically and empower them to address social factors to improve health. Given the agency’s history, the members of the National Advisory Council believe the AHRQ is in position to lead the effort and are calling for enhanced collaboration to address systemic racism and societal inequities around health and healthcare.  

Dr. Embí is currently serving a three-year term on the Advisory Council, which provides advice and recommendations to the AHRQ director and secretary of the U.S. Department of Health and Human Services on priorities for a national health services research agenda.  

In addition to Dr. Embí, other authors on the blog are Edmondo Robinson, M.D. MBA., M.S. of the Moffitt Cancer Center; Ramanathan Raju, M.D., formerly of New York City Health and Hospitals Corporation and Yanling Yu, PhD of Washington Advocates for patient safety. 

Read the entire blog post here

About Peter Embí, M.D., M.S.

In addition to serving as the president and CEO of Regenstrief Institute, Peter Embí, M.D., M.S. is the Leonard Betley Professor of Medicine and associate dean for informatics and health services research at Indiana University School of Medicine, associate director of informatics with the Indiana Clinical and Translational Sciences Institute and vice president for Learning Health Systems with Indiana University Health. 

Related News

Rachel Patzer, PhD

Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa

Published in JAMA Dermatology. Here is a link to the article.   Regenstrief Institute authors:  Rachel Patzer, PhD, MPH

Thomas Imperiale

Next generation stool DNA test has best detection rate of noninvasive colorectal cancer screening tools

Study of highly sensitive noninvasive test published in New England Journal of Medicine A study of more than 21,000

Rachel Patzer, PhD, MPH and Kalli Koukounas, MPH

JAMA study finds facilities treating poor patients penalized by CMS payment model

Social risk and treatment for end-stage kidney disease A new study of more than 2,000 dialysis facilities randomized to